Anti-hypertensive and pleiotropic effects of Moringa oleifera leaf extract as an add-on therapy in patients with essential hypertension - A randomized double blind placebo controlled trial. - NI

JIPMER Puducherry0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•Patients with essential hypertension aged = 18 years, irrespective of gender, with or without other comorbidities, who fulfill the following criteria:
•Patients on treatment with stable dose of antihypertensive agents for atleast 1 month and has not yet attained target blood pressure goals (130 mm Hg of systolic and 80 mm Hg of diastolic blood pressure) and not requiring dose escalation or addition of new anti-hypertensive agent according to clinical judgment of the treating physician.

•Patients with secondary hypertension.
•Patients with resistant hypertension.
•Patients with hypertensive urgency or emergency.
•Patients not on stable dose of oral hypoglycemic drugs or insulin for past 1 month.
•Pregnant and lactating women, women in reproductive age group not practicing contraceptive measures.
•Patients with hepatic impairment (elevated liver enzymes more than 2 times upper normal limit)
•Patients with renal impairment (serum Creatinine more than 1.2 mg per dl)
•Patients with recent history of coronary artery disease
•Patients with peripheral vascular disease.
•Patients who had participated in other trials in the past three months.
•Patients on other herbal medications.

发起方